跳至主要内容
临床试验/KCT0000157
KCT0000157招募中未知

A multicentre, prospective randomized study to assess the effect when GnRH antagonist is started either on stimulation day 1 and day 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndrome undergoing IVF/ET

Seoul National University Hospital0 个研究点目标入组 267 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
267

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 40(Year)(—)
性别
Female

入选标准

  • PCOS patients (diagnosed as 2003 ASRM/ESHRE consensus meeting guideline)
  • age 20-40 years
  • patients who have normal uterus

排除标准

  • patients who have abnormal thyroid function
  • patients who have abnormal prolactin test
  • patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia, or androgen-producing tumor.
  • Patients who reject informed consent
  • patients who have experience of adverse events for GnRH agonist, antagonist, recombinant FSH.

研究者

相似试验